Cancer Research Technology
Log in Register
Menu

Anti-Microglobulin ß2, Recombinant [BBM.1]

Invented by Prof Walter Bodmer at University of Oxford, Absolute Antibody

Info

Catalogue Number 153361
Applications FACS IHC IP Fn
Antigen/Gene or Protein Targets Microglobulin Beta 2
Reactivity Human
Relevance Beta2-microglobulin associates with human leucocyte antigens (HLAs). BBM.1 binds significantly with fibroblasts and lymphocytes from humans and primates and can be used for the detection of Beta2-microglobulin in myeloma and other conditions (serum assay kits etc.). BBM.1 binds equivalently to free and HLA-associated Beta2-microglobulin and may be used for detection in myeloma and other conditions (e.g. within serum assay kits).
Host Mouse
Immunogen Molt 4, a human T cell line.
Subclass IgG2b
Formulation PBS
Concentration 1mg/ml
Research Area Cancer, Cardiovascular
Notes Recombinant monoclonal antibody produced from the original monoclonal. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma.

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Original hybridoma first published in: Brodsky et al. 1979. Eur J Immunol. 9(7):536-45. PMID: 91522.


Add a reference

References: 1 entry

Original hybridoma first published in: Brodsky et al. 1979. Eur J Immunol. 9(7):536-45. PMID: 91522.


Add a reference